Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Alzheimer Disease 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, Follicular 2Dementia 2Cognitive Dysfunction 2Stress Disorders, Post-Traumatic 1Sleep Initiation and Maintenance Disorders 1Sleep Disorders, Circadian Rhythm 1Sleep Deprivation 1REM Sleep Behavior Disorder 1Psychological Well-Being 1Pain 1Otolaryngeal Cancer 1Neoplasm Metastasis 1Idiopathic Hypersomnia 1Depression 1Combat Disorders 1Chronobiology Disorders 1Cancer Pain 1Breast Neoplasms 1Anxiety Disorders 1Agnosia 1

Interventions

Saline Solution 1Ketamine 1Electroencephalography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Otolaryngeal Cancer × Electroencephalography × Clear all
NCT03040024 2021-07-08

Delirium Prevention With Ketamine in Ear, Nose, and Throat (ENT) Patients

Emory University

Phase 4 Terminated
71 enrolled 17 charts
Head & Neck

Otolaryngeal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡